Back to Search Start Over

Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden.

Authors :
Ericsson, Åsa
Fridhammar, Adam
Source :
Journal of Medical Economics; Oct2019, Vol. 22 Issue 10, p997-1005, 9p
Publication Year :
2019

Details

Language :
English
ISSN :
13696998
Volume :
22
Issue :
10
Database :
Complementary Index
Journal :
Journal of Medical Economics
Publication Type :
Academic Journal
Accession number :
138615157
Full Text :
https://doi.org/10.1080/13696998.2019.1614009